|
TRA2B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99680288865056E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25230000205912E-08 |
| Normal-vs-Stage2 |
1.57793999999711E-05 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
4.232600E-04 |
| Stage1-vs-Stage2 |
9.725600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
4.349000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
3.773800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.38902256153051E-13 |
| Normal-vs-AfricanAmerican |
1.856040E-01 |
| Normal-vs-Asian |
7.39929999493683E-08 |
| Caucasian-vs-AfricanAmerican |
8.355800E-01 |
| Caucasian-vs-Asian |
5.538600E-01 |
| AfricanAmerican-vs-Asian |
7.385400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11219999987533E-07 |
| Normal-vs-Female |
3.353100019865E-10 |
| Male-vs-Female |
5.068200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.158200E-04 |
| Normal-vs-Extreme_Weight |
4.82849999983159E-08 |
| Normal-vs-Obese |
3.85459999999727E-05 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.108800E-01 |
| Normal_Weight-vs-Obese |
8.005800E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.317990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
9.518800E-01 |
| Normal-vs-Grade 3 |
5.879000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
2.213800E-01 |
| Grade 2-vs-Grade 4 |
9.518800E-01 |
| Grade 3-vs-Grade 4 |
5.879000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88069559925452E-11 |
| Normal-vs-N1 |
5.05769981451465E-10 |
| N0-vs-N1 |
6.174100E-02 |
|
|
